117 results
Page 2 of 6
8-K
EX-99.1
grt6uatycxc9mjj
27 Jul 23
55% objective response rate; 23% complete response rate in locally advanced cSCC
7:30am
424B5
memha958jv2gugt0
24 May 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
pp0z00hlm6vv 69ts5
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-10.1
yssdhvv
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-99.1
dyd0pifwzw01s
15 May 23
Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
4:21pm
8-K
EX-10.1
79xdky 2hlpp1p4rpub
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-99.1
it4ik1
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
424B5
wb7wmv08315a9ws6 37
4 Apr 23
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
e6f2fna
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-10.1
6vj ntv9ut7
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-99.1
iicnr3afye ga9f
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
424B5
7uu3h93fw ewgdmz
16 Dec 22
Prospectus supplement for primary offering
7:00am
8-K
EX-99.1
6j4ybvp
5 Dec 22
Checkpoint Therapeutics Announces Reverse Stock Split
4:45pm
8-K
EX-99.1
g4z0 zekgj
8 Nov 22
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:43pm
8-K
EX-99.1
3mc31pptcr0o 6pjj
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am